These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 15523902

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serum p53 autoantibodies as prognostic marker in patients with oesophageal carcinoma.
    Bergqvist AS, Bergqvist M, Brattstrom D, Hesselius P, Larsson A, Brodin O, Wagenius G.
    Anticancer Res; 2001; 21(6A):4141-5. PubMed ID: 11911308
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Prognostic value of antibodies against p53 in patients with oral squamous cell carcinoma--five years survival rate].
    Hofele C, Schwager-Schmitt M, Volkmann M.
    Laryngorhinootologie; 2002 May; 81(5):342-5. PubMed ID: 12001023
    [Abstract] [Full Text] [Related]

  • 7. The detection of serum anti-p53 antibodies from patients with gastric carcinoma in China.
    Qiu LL, Hua PY, Ye LL, Wang YC, Qiu T, Bao HZ, Wang L.
    Cancer Detect Prev; 2007 May; 31(1):45-9. PubMed ID: 17292563
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. P53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy.
    Bergqvist M, Brattström D, Larsson A, Holmertz J, Hesselius P, Rosenberg L, Wagenius G, Brodin O.
    Anticancer Res; 1998 May; 18(3B):1999-2002. PubMed ID: 9677456
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy.
    Blanchard P, Quero L, Pacault V, Schlageter MH, Baruch-Hennequin V, Hennequin C.
    BMC Cancer; 2012 Mar 26; 12():119. PubMed ID: 22448886
    [Abstract] [Full Text] [Related]

  • 13. Clinico-pathological characteristics of colorectal cancer and serum anti-p53 antibodies.
    Bielicki D, Karbowniczek M, Sulzyc-Bielicka V, Kładny J, Boer C, Marlicz K, Domagała W.
    Pol J Pathol; 1999 Mar 26; 50(2):77-81. PubMed ID: 10481530
    [Abstract] [Full Text] [Related]

  • 14. [Antibody formation to cellular p53 protein in patients with squamous cell carcinomas of the upper respiratory and digestive system].
    Maass JD, Gottschlich S, Lippert BM, Niemann AM, Görögh T, Werner JA.
    Laryngorhinootologie; 1996 Jan 26; 75(1):53-6. PubMed ID: 8851121
    [Abstract] [Full Text] [Related]

  • 15. Anti-p53 and anti-heat shock proteins antibodies in patients with malignant or pre-malignant lesions of the oral cavity.
    Castelli M, Cianfriglia F, Manieri A, Palma L, Pezzuto RW, Falasca G, Delpino A.
    Anticancer Res; 2001 Jan 26; 21(1B):753-8. PubMed ID: 11299839
    [Abstract] [Full Text] [Related]

  • 16. Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.
    Müller M, Meyer M, Schilling T, Ulsperger E, Lehnert T, Zentgraf H, Stremmel W, Volkmann M, Galle PR.
    Int J Oncol; 2006 Oct 26; 29(4):973-80. PubMed ID: 16964393
    [Abstract] [Full Text] [Related]

  • 17. Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group.
    Shimada H, Ochiai T, Nomura F, Japan p53 Antibody Research Group.
    Cancer; 2003 Feb 01; 97(3):682-9. PubMed ID: 12548611
    [Abstract] [Full Text] [Related]

  • 18. [Detection of serum anti-p53 antibodies in patients with various types of cancer].
    Sakai H.
    Rinsho Byori; 2002 Jan 01; 50(1):90-2. PubMed ID: 11871143
    [Abstract] [Full Text] [Related]

  • 19. The presence of serum anti-p53 antibodies from patients with invasive ductal carcinoma of breast: correlation to other clinical and biological parameters.
    Gao RJ, Bao HZ, Yang Q, Cong Q, Song JN, Wang L.
    Breast Cancer Res Treat; 2005 Sep 01; 93(2):111-5. PubMed ID: 16187230
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.